The Clinical and Pathological Significance of Nectin-2 and DDX3 Expression in Pancreatic Ductal Adenocarcinomas

Table 3

Correlations of clinicopathological characteristics and Nectin-2 and DDX3 expression with mean survival in patients with pancreatic ductal adenocarcinoma.

Groups	Case number ()	Mean survival (median); month		value
Sex
Male	61	9.98 (13)	1.656	0.198
Female	45	8.61 (11.5)
Age (year)
≤45	22	8.18 (11)	2.144	0.143
>45	84	9.73 (13)
Differentiation
Well	38	11.27 (13.5)	17.786	0.000
Moderately	35	9.74 (12)
Poorly	33	6.86 (8)
Tumor size
<3 cm	13	13.46 (13)	7.504	0.023
3~5 cm	68	9.34 (12)
>5 cm	25	7.40 (13.5)
TNM stage
I	11	16.46 (17.5)	80.807	0.000
II	42	11.37 (12.5)
III	37	7.14 (9.5)
IV	16	4.56 (5)
Lymph node metastasis
No	77	10.64 (13)	27.120	0.000
Yes	29	6.35 (7)
Invasion
No	42	13.33 (14.5)	46.949	0.000
Yes	54	6.83 (9.5)
Nectin-2
−	48	12.63 (13.5)	44.074	0.000
+	56	6.73 (8.5)
DDX3
−	55	12.05 (14.5)	28.608	0.000
+	51	6.98 (10)